Skip to main content
. 2021 Dec 28;13(2):251–264. doi: 10.1007/s13300-021-01192-x

Fig. 4.

Fig. 4

Proportions of patients with available screening data for CKD and retinopathy. n denotes the total number of patients, except for consultation by ophthalmologist (for which n denotes the number of patients for whom microvascular complications were investigated)